A positive relation between audibility and speech understanding has been established for cochlear implant (CI) recipients. Sound field thresholds of 20 dB HL across the frequency range provide CI users the opportunity to understand soft and very soft speech. However, programming the sound processor to attain good audibility can be time-consuming and difficult for some patients. To address these issues, Advanced Bionics (AB) developed the SoftVoice algorithm designed to remove system noise and thereby improve audibility of soft speech. The present study aimed to evaluate the efficacy of SoftVoice in optimizing AB CI recipients’ soft-speech perception.
Two studies were conducted. Study 1 had two phases, 1A and 1B. Sixteen adult, AB CI recipients participated in Study 1A. Acute testing was performed in the unilateral CI condition using a Harmony processor programmed with participants’ everyday-use program (Everyday) and that same program but with SoftVoice implemented. Speech recognition measures were administered at several presentation levels in quiet (35 to 60 dB SPL) and in noise (60 dB SPL). In Study 1B, 10 of the participants compared Everyday and SoftVoice at home to obtain feedback regarding the use of SoftVoice in various environments. During Study 2, soft-speech perception was acutely measured with Everyday and SoftVoice for 10 participants using the Naida CI Q70 processor. Results with the Harmony (Study 1A) and Naida processors were compared. Additionally, Study 2 evaluated programming options for setting electrode threshold levels (T-levels or Ts) to improve the usability of SoftVoice in daily life.
Study 1A showed significantly higher scores with SoftVoice than Everyday at soft presentation levels (35, 40, 45, and 50 dB SPL) and no significant differences between programs at a conversational level (60 dB SPL) in quiet or in noise. After take-home experience with SoftVoice and Everyday (Study 1B), 5 of 10 participants reported preferring SoftVoice over Everyday; however, 6 reported bothersome environmental sound when listening with SoftVoice at home. Results of Study 2 indicated similar soft-speech perception between Harmony and Naida processors. Additionally, implementing SoftVoice with Ts at the manufacturer’s default setting of 10% of Ms reduced reports of bothersome environmental sound during take-home experience; however, soft-speech perception was best with SoftVoice when Ts were behaviorally set above 10% of Ms.
Results indicate that SoftVoice may be a potential tool for optimizing AB users’ audibility and, in turn, soft-speech perception. To achieve optimal performance at soft levels and comfortable use in daily environments, setting Ts must be considered with SoftVoice. Future research should examine program parameters that may benefit soft-speech perception when used in combination with SoftVoice (e.g., increased input dynamic range).
1Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St. Louis, Missouri, USA
2Advanced Bionics, LLC, Valencia, California, USA.
ACKNOWLEDGMENTS: The authors express their appreciation to the participants who graciously gave their time and effort to participate in this study and to Chris Brenner who assisted with data entry and editing parts of the manuscript.
This research was supported by funds from Advanced Bionics, LLC and from NIH/NIDCD R01DC009010.
The authors L.K.H., J.B.F., R.M.R., A.L.S., and L.M.L. designed the study, analyzed and interpreted data, and contributed to the writing of the manuscript. L.K.H. and N.Y.D. collected the data. N.Y.D. also assisted with interpretation of the data and writing the manuscript.
A.L.S. and L.M.L. are employed by Advanced Bionics, LLC. J.B.F. serves on the audiology advisory boards for Advanced Bionics, LLC and Cochlear Americas.
Address for correspondence: Laura K. Holden, Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, 4523 Clayton Avenue, Campus Box 8115, St. Louis, MO 63110. E-mail: firstname.lastname@example.org
Received March 23, 2018; accepted September 27, 2018.